These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes. Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130 [TBL] [Abstract][Full Text] [Related]
25. Paraganglioma in a 13-year-old girl: a novel SDHB gene mutation in the family? Musil Z; Puchmajerová A; Krepelová A; Vícha A; Panczak A; Veselá J; Widimský J; Turková H; Lisý J; Kohoutová M Cancer Genet Cytogenet; 2010 Mar; 197(2):189-92. PubMed ID: 20193854 [No Abstract] [Full Text] [Related]
27. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]
28. Malignant bladder pheochromocytoma with SDHB genetic mutation. Maeda M; Funahashi Y; Katoh M; Fujita T; Tsuruta K; Gotoh M Aktuelle Urol; 2013 Sep; 44(5):381-2. PubMed ID: 23807799 [TBL] [Abstract][Full Text] [Related]
29. [Intrapericardical paraganglioma associated with mutation in succinate dehydrogenase enzyme gene]. Diéguez Felechosa M; Pun Y; Laurés AS; Casal Alvarez F Med Clin (Barc); 2015 Mar; 144(5):236-7. PubMed ID: 24939699 [No Abstract] [Full Text] [Related]
30. Screening: Correlation of genotype and phenotype in paraganglioma. Baysal BE Nat Rev Endocrinol; 2009 Nov; 5(11):594-5. PubMed ID: 19844247 [No Abstract] [Full Text] [Related]
31. Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy. Poeppel TD; Yuece A; Boy C; Metz KA; Kaminsky E; Neumann HP; Rosenbaum SJ; Mann K; Moeller LC J Clin Oncol; 2011 Nov; 29(33):e812-5. PubMed ID: 22025150 [No Abstract] [Full Text] [Related]
32. Modern PET imaging for paragangliomas: relation to genetic mutations. Taïeb D; Rubello D; Al-Nahhas A; Calzada M; Marzola MC; Hindié E Eur J Surg Oncol; 2011 Aug; 37(8):662-8. PubMed ID: 21636242 [TBL] [Abstract][Full Text] [Related]
33. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy. Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417 [TBL] [Abstract][Full Text] [Related]
35. SDHB gene positive metastatic paraganglioma associated with lesions which demonstrate both positive and negative uptake of 18FDG PET and 131MIBG. Casey R; Slattery D; Prendeville S; Moore M; Maher M; O'Halloran D QJM; 2013 Nov; 106(11):1035-7. PubMed ID: 23708795 [No Abstract] [Full Text] [Related]
36. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297 [TBL] [Abstract][Full Text] [Related]
37. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171 [TBL] [Abstract][Full Text] [Related]